D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 76 Citations 17,939 284 World Ranking 402 National Ranking 11

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

His main research concerns Microbiology, Antibacterial agent, Klebsiella pneumoniae, Ertapenem and Pharmacology. His study in Microbiology concentrates on Drug resistance, Antimicrobial, Imipenem, Meropenem and Ciprofloxacin. His research in Ciprofloxacin intersects with topics in Ampicillin, Levofloxacin, Antibiotic resistance and Trimethoprim.

His studies in Antibacterial agent integrate themes in fields like Tigecycline, Streptococcus pneumoniae and Virology. The various areas that Daryl J. Hoban examines in his Klebsiella pneumoniae study include Amikacin, Cefepime, Pseudomonas aeruginosa, Proteus mirabilis and Broth microdilution. His Pharmacology study combines topics from a wide range of disciplines, such as Anaerobic bacteria, Avibactam and Gemifloxacin.

His most cited work include:

  • Comparative review of the carbapenems. (394 citations)
  • A Critical Review of the Fluoroquinolones (280 citations)
  • A Critical Review of the Fluoroquinolones (280 citations)

What are the main themes of his work throughout his whole career to date?

Daryl J. Hoban mainly focuses on Microbiology, Antibacterial agent, Tigecycline, Antimicrobial and Streptococcus pneumoniae. His research is interdisciplinary, bridging the disciplines of Klebsiella pneumoniae and Microbiology. His biological study spans a wide range of topics, including Minimum inhibitory concentration, Enterococcus faecium, Pharmacodynamics and Gentamicin.

The study incorporates disciplines such as In vitro, Vancomycin, Staphylococcus aureus, Meropenem and Internal medicine in addition to Tigecycline. His Antimicrobial research is multidisciplinary, incorporating perspectives in Multiple drug resistance and Cephalosporin. Daryl J. Hoban interconnects Penicillin, Streptococcaceae and Serotype, Virology in the investigation of issues within Streptococcus pneumoniae.

He most often published in these fields:

  • Microbiology (83.06%)
  • Antibacterial agent (24.10%)
  • Tigecycline (21.82%)

What were the highlights of his more recent work (between 2012-2021)?

  • Microbiology (83.06%)
  • Antibiotic resistance (16.29%)
  • Klebsiella pneumoniae (15.31%)

In recent papers he was focusing on the following fields of study:

Daryl J. Hoban mostly deals with Microbiology, Antibiotic resistance, Klebsiella pneumoniae, Antimicrobial and Ertapenem. Amikacin, Imipenem, Broth microdilution, Cephalosporin and Drug resistance are among the areas of Microbiology where he concentrates his study. His work in Cephalosporin tackles topics such as Ceftazidime which are related to areas like Tazobactam and Meropenem.

His Drug resistance study combines topics in areas such as Ciprofloxacin and Streptococcus pneumoniae. His work deals with themes such as Penicillin and Levofloxacin, which intersect with Antimicrobial. The concepts of his Ertapenem study are interwoven with issues in Tigecycline, Cefoxitin, Beta-lactamase and Cefotaxime.

Between 2012 and 2021, his most popular works were:

  • Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. (242 citations)
  • Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. (242 citations)
  • Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli (206 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

Daryl J. Hoban focuses on Microbiology, Cephalosporin, Amikacin, Pharmacology and Imipenem. Microbiology is a component of his Antibiotic resistance, Ertapenem, Antimicrobial, Tazobactam and Meropenem studies. His work carried out in the field of Ertapenem brings together such families of science as Ciprofloxacin and Levofloxacin.

The Cephalosporin study combines topics in areas such as Ceftazidime, Pseudomonas aeruginosa and Urinary system. His Pharmacology study combines topics in areas such as Anaerobic bacteria and Avibactam. His research in Pharmacokinetics tackles topics such as Antibacterial agent which are related to areas like Tigecycline.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comparative review of the carbapenems.

George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson.
Drugs (2007)

649 Citations

A Critical Review of the Fluoroquinolones

George G. Zhanel;George G. Zhanel;Kelly Ennis;Lavern Vercaigne;Andrew Walkty.
Drugs (2002)

429 Citations

Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System

Christine Y. Turenne;Steven E. Sanche;Daryl J. Hoban;James A. Karlowsky.
Journal of Clinical Microbiology (1999)

419 Citations

Review of macrolides and ketolides: focus on respiratory tract infections.

George G. Zhanel;Maria Dueck;Daryl J. Hoban;Lavern M. Vercaigne.
Drugs (2001)

355 Citations

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer.
Drugs (2013)

349 Citations

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby.
International Journal of Antimicrobial Agents (2006)

321 Citations

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

George G. Zhanel;Mel DeCorby;Nancy Laing;Barb Weshnoweski.
Antimicrobial Agents and Chemotherapy (2008)

320 Citations

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

Susan E. Dorman;John L. Johnson;Stefan Goldberg;Grace Muzanye.
American Journal of Respiratory and Critical Care Medicine (2009)

316 Citations

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Stephen P. Hawser;Samuel K. Bouchillon;Daryl J. Hoban;Robert E. Badal.
Antimicrobial Agents and Chemotherapy (2009)

298 Citations

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby.
International Journal of Antimicrobial Agents (2005)

293 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Daryl J. Hoban

George G. Zhanel

George G. Zhanel

University of Manitoba

Publications: 141

James A. Karlowsky

James A. Karlowsky

University of Manitoba

Publications: 91

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 87

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 82

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 77

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 68

Po-Ren Hsueh

Po-Ren Hsueh

National Taiwan University

Publications: 68

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 50

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 50

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 47

David L. Paterson

David L. Paterson

University of Queensland

Publications: 47

Robert A. Bonomo

Robert A. Bonomo

United States Department of Veterans Affairs

Publications: 46

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 41

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 41

Johann D. D. Pitout

Johann D. D. Pitout

University of Calgary

Publications: 39

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 30

Trending Scientists

Subhasish Mitra

Subhasish Mitra

Stanford University

Shahid Abbas Abbasi

Shahid Abbas Abbasi

Pondicherry University

Xiaogang Peng

Xiaogang Peng

Zhejiang University

Thomas Brey

Thomas Brey

Alfred Wegener Institute for Polar and Marine Research

John J. Magnuson

John J. Magnuson

University of Wisconsin–Madison

Hisayoshi Nozaki

Hisayoshi Nozaki

University of Tokyo

Jorge Caamano

Jorge Caamano

University of Birmingham

Xin Gen Lei

Xin Gen Lei

Cornell University

C H Heldin

C H Heldin

Ludwig Cancer Research

Francesco Barchiesi

Francesco Barchiesi

Marche Polytechnic University

R. Todd Constable

R. Todd Constable

Yale University

Rodrigo B. Mansur

Rodrigo B. Mansur

University Health Network

Stephan J. Motowidlo

Stephan J. Motowidlo

Rice University

Suzette Delaloge

Suzette Delaloge

Institut Gustave Roussy

Jun'ichi Yokoyama

Jun'ichi Yokoyama

University of Tokyo

William H. Matthaeus

William H. Matthaeus

University of Delaware

Something went wrong. Please try again later.